Related content

Recursive partitioning analysis of complex disease pharmacogenetic studies. I. Motivation and overview

By Young S Stanley   Ge Nanxiang  

Pharmacogenomics, Vol. 6, Iss. 1, 2005-01 ,pp. : 65-75

Future Medicine

Access to resources Recommend Favorite

Anti-Parkinson's disease drugs and pharmacogenetic considerations

By Agúndez José A G  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 7, 2013-07 ,pp. : 859-874

Informa Healthcare

Access to resources Recommend Favorite

The Pathway Less Traveled: Moving from Candidate Genes to Candidate Pathways in the Analysis of Genome-Wide Data from Large Scale Pharmacogenetic Association Studies

By  

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 6, Iss. 3, 2008-09 ,pp. : 150-159

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenetic Considerations in the Elderly Patient

By Bright David R.   Calinski Diane M.   Kisor David F.  

The Consultant Pharmacist, Vol. 30, Iss. 4, 2015-04 ,pp. : 228-239

American Society of Consultant Pharmacists

Access to resources Recommend Favorite

Solubility Prediction by Recursive Partitioning

By Xia X.   Maliski E.   Cheetham J.   Poppe L.  

Pharmaceutical Research, Vol. 20, Iss. 10, 2003-10 ,pp. : 1634-1640

Springer Publishing Company

Access to resources Recommend Favorite